Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | SFMBT1 | Human | (-)-epigallocatechin 3-gallate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SFMBT1 mRNA | CTD | PMID:22079256 | SFMBT1 | Human | (1->4)-beta-D-glucan | multiple interactions | ISO | Sfmbt1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SFMBT1 mRNA | CTD | PMID:36331819 | SFMBT1 | Human | 1,2-dimethylhydrazine | increases expression | ISO | Sfmbt1 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of SFMBT1 mRNA | CTD | PMID:22206623 | SFMBT1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Sfmbt1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SFMBT1 mRNA | CTD | PMID:21354282 | SFMBT1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Sfmbt1 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SFMBT1 mRNA | CTD | PMID:34747641 | SFMBT1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Sfmbt1 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of SFMBT1 mRNA | CTD | PMID:32109520 | SFMBT1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of SFMBT1 mRNA | CTD | PMID:22574217 | SFMBT1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Sfmbt1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of SFMBT1 mRNA | CTD | PMID:21570461 | SFMBT1 | Human | 2,3,7,8-Tetrachlorodibenzofuran | affects expression | ISO | Sfmbt1 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:32109520 | SFMBT1 | Human | 3,3',4,4',5-pentachlorobiphenyl | increases expression | ISO | Sfmbt1 (Rattus norvegicus) | 6480464 | 3 more ... | CTD | PMID:23196670 | SFMBT1 | Human | 3,4-methylenedioxymethamphetamine | increases expression | ISO | Sfmbt1 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of SFMBT1 mRNA | CTD | PMID:20188158 | SFMBT1 | Human | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Sfmbt1 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of SFMBT1 mRNA | CTD | PMID:26251327 | SFMBT1 | Human | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SFMBT1 mRNA | CTD | PMID:28628672 | SFMBT1 | Human | 4,4'-diaminodiphenylmethane | increases expression | ISO | Sfmbt1 (Mus musculus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in increased expression of SFMBT1 mRNA | CTD | PMID:18648102 | SFMBT1 | Human | 4,4'-diaminodiphenylmethane | decreases expression | ISO | Sfmbt1 (Mus musculus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in decreased expression of SFMBT1 mRNA | CTD | PMID:18648102 | SFMBT1 | Human | 7,9-dihydro-1H-purine-2,6,8(3H)-trione | affects abundance | EXP | | 6480464 | SFMBT1 gene SNP affects the abundance of Uric Acid | CTD | PMID:23263486 | SFMBT1 | Human | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of SFMBT1 mRNA | CTD | PMID:32763439 | SFMBT1 | Human | aflatoxin B1 | increases expression | ISO | Sfmbt1 (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of SFMBT1 mRNA | CTD | PMID:19770486 | SFMBT1 | Human | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of SFMBT1 gene and Aflatoxin B1 results in decreased methylation of SFMBT1 intron | CTD | PMID:27153756 and PMID:30157460 | SFMBT1 | Human | Aflatoxin B2 alpha | decreases methylation | EXP | | 6480464 | aflatoxin B2 results in decreased methylation of SFMBT1 intron | CTD | PMID:30157460 | SFMBT1 | Human | ammonium chloride | affects expression | ISO | Sfmbt1 (Rattus norvegicus) | 6480464 | Ammonium Chloride affects the expression of SFMBT1 mRNA | CTD | PMID:16483693 | SFMBT1 | Human | amphetamine | decreases expression | ISO | Sfmbt1 (Rattus norvegicus) | 6480464 | Amphetamine results in decreased expression of SFMBT1 mRNA | CTD | PMID:30779732 | SFMBT1 | Human | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of SFMBT1 mRNA | CTD | PMID:33212167 | SFMBT1 | Human | arsane | multiple interactions | EXP | | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SFMBT1 mRNA | CTD | PMID:32525701 | SFMBT1 | Human | arsenic atom | multiple interactions | EXP | | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SFMBT1 mRNA | CTD | PMID:32525701 | SFMBT1 | Human | atrazine | affects methylation | ISO | Sfmbt1 (Rattus norvegicus) | 6480464 | Atrazine affects the methylation of SFMBT1 gene | CTD | PMID:28931070 | SFMBT1 | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of SFMBT1 promoter | CTD | PMID:27901495 | SFMBT1 | Human | benzo[a]pyrene | increases methylation | ISO | Sfmbt1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased methylation of SFMBT1 intron | CTD | PMID:27901495 | SFMBT1 | Human | benzo[e]pyrene | decreases methylation | EXP | | 6480464 | benzo(e)pyrene results in decreased methylation of SFMBT1 intron | CTD | PMID:30157460 | SFMBT1 | Human | bisphenol A | increases expression | ISO | Sfmbt1 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of SFMBT1 mRNA | CTD | PMID:25181051 more ... | SFMBT1 | Human | bisphenol A | decreases methylation | EXP | | 6480464 | bisphenol A results in decreased methylation of SFMBT1 gene | CTD | PMID:31601247 | SFMBT1 | Human | bisphenol A | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SFMBT1 mRNA | CTD | PMID:28628672 | SFMBT1 | Human | bisphenol A | increases methylation | ISO | Sfmbt1 (Rattus norvegicus) | 6480464 | bisphenol A results in increased methylation of SFMBT1 gene | CTD | PMID:28505145 | SFMBT1 | Human | bisphenol F | increases methylation | EXP | | 6480464 | bisphenol F results in increased methylation of SFMBT1 gene | CTD | PMID:31601247 | SFMBT1 | Human | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of SFMBT1 mRNA | CTD | PMID:38568856 | SFMBT1 | Human | caffeine | increases phosphorylation | EXP | | 6480464 | Caffeine results in increased phosphorylation of SFMBT1 protein | CTD | PMID:35688186 | SFMBT1 | Human | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to SFMBT1 gene] | CTD | PMID:28238834 | SFMBT1 | Human | ciguatoxin CTX1B | affects expression | ISO | Sfmbt1 (Mus musculus) | 6480464 | Ciguatoxins affects the expression of SFMBT1 mRNA | CTD | PMID:18353800 | SFMBT1 | Human | cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of SFMBT1 mRNA | CTD | PMID:27392435 | SFMBT1 | Human | coumarin | decreases phosphorylation | EXP | | 6480464 | coumarin results in decreased phosphorylation of SFMBT1 protein | CTD | PMID:35688186 | SFMBT1 | Human | dexamethasone | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SFMBT1 mRNA | CTD | PMID:28628672 | SFMBT1 | Human | Dibutyl phosphate | affects expression | EXP | | 6480464 | di-n-butylphosphoric acid affects the expression of SFMBT1 mRNA | CTD | PMID:37042841 | SFMBT1 | Human | dibutyl phthalate | decreases expression | ISO | Sfmbt1 (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of SFMBT1 mRNA | CTD | PMID:21266533 | SFMBT1 | Human | dioxygen | decreases expression | EXP | | 6480464 | Oxygen deficiency results in decreased expression of SFMBT1 mRNA | CTD | PMID:26516004 | SFMBT1 | Human | disodium selenite | increases expression | EXP | | 6480464 | Sodium Selenite results in increased expression of SFMBT1 mRNA | CTD | PMID:18175754 | SFMBT1 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | SFMBT1 | Human | folic acid | decreases expression | ISO | Sfmbt1 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of SFMBT1 mRNA | CTD | PMID:25629700 | SFMBT1 | Human | indometacin | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SFMBT1 mRNA | CTD | PMID:28628672 | SFMBT1 | Human | methapyrilene | decreases methylation | EXP | | 6480464 | Methapyrilene results in decreased methylation of SFMBT1 intron | CTD | PMID:30157460 | SFMBT1 | Human | methyl methanesulfonate | increases expression | EXP | | 6480464 | Methyl Methanesulfonate results in increased expression of SFMBT1 mRNA | CTD | PMID:23649840 | SFMBT1 | Human | methylmercury chloride | decreases expression | EXP | | 6480464 | methylmercuric chloride results in decreased expression of SFMBT1 mRNA | CTD | PMID:28001369 | SFMBT1 | Human | panobinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SFMBT1 mRNA | CTD | PMID:27188386 | SFMBT1 | Human | panobinostat | decreases expression | EXP | | 6480464 | panobinostat results in decreased expression of SFMBT1 mRNA | CTD | PMID:26272509 | SFMBT1 | Human | paracetamol | increases expression | ISO | Sfmbt1 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of SFMBT1 mRNA | CTD | PMID:33387578 | SFMBT1 | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Sfmbt1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SFMBT1 mRNA | CTD | PMID:36331819 | SFMBT1 | Human | phenobarbital | affects expression | ISO | Sfmbt1 (Mus musculus) | 6480464 | Phenobarbital affects the expression of SFMBT1 mRNA | CTD | PMID:23091169 | SFMBT1 | Human | phenylmercury acetate | decreases expression | EXP | | 6480464 | Phenylmercuric Acetate results in decreased expression of SFMBT1 mRNA | CTD | PMID:26272509 | SFMBT1 | Human | phenylmercury acetate | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SFMBT1 mRNA | CTD | PMID:27188386 | SFMBT1 | Human | potassium chromate | decreases expression | EXP | | 6480464 | potassium chromate(VI) results in decreased expression of SFMBT1 mRNA | CTD | PMID:22079256 | SFMBT1 | Human | potassium chromate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SFMBT1 mRNA | CTD | PMID:22079256 | SFMBT1 | Human | pregnenolone 16alpha-carbonitrile | increases expression | ISO | Sfmbt1 (Rattus norvegicus) | 6480464 | Pregnenolone Carbonitrile results in increased expression of SFMBT1 mRNA | CTD | PMID:19162173 | SFMBT1 | Human | propiconazole | increases expression | ISO | Sfmbt1 (Mus musculus) | 6480464 | propiconazole results in increased expression of SFMBT1 mRNA | CTD | PMID:21278054 | SFMBT1 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | SFMBT1 | Human | sodium arsenate | multiple interactions | EXP | | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SFMBT1 mRNA | CTD | PMID:32525701 | SFMBT1 | Human | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of SFMBT1 mRNA | CTD | PMID:38568856 | SFMBT1 | Human | sodium arsenite | decreases expression | ISO | Sfmbt1 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of SFMBT1 mRNA | CTD | PMID:37682722 | SFMBT1 | Human | sunitinib | increases expression | EXP | | 6480464 | Sunitinib results in increased expression of SFMBT1 mRNA | CTD | PMID:31533062 | SFMBT1 | Human | titanium dioxide | increases methylation | ISO | Sfmbt1 (Mus musculus) | 6480464 | titanium dioxide results in increased methylation of SFMBT1 gene | CTD | PMID:35295148 | SFMBT1 | Human | titanium dioxide | decreases methylation | ISO | Sfmbt1 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of SFMBT1 promoter | CTD | PMID:35295148 | SFMBT1 | Human | triphenyl phosphate | affects expression | EXP | | 6480464 | triphenyl phosphate affects the expression of SFMBT1 mRNA | CTD | PMID:37042841 | SFMBT1 | Human | triptonide | increases expression | ISO | Sfmbt1 (Mus musculus) | 6480464 | triptonide results in increased expression of SFMBT1 mRNA | CTD | PMID:33045310 | SFMBT1 | Human | troglitazone | decreases expression | ISO | Sfmbt1 (Mus musculus) | 6480464 | troglitazone results in decreased expression of SFMBT1 mRNA | CTD | PMID:28973697 | SFMBT1 | Human | valdecoxib | increases expression | ISO | Sfmbt1 (Rattus norvegicus) | 6480464 | valdecoxib results in increased expression of SFMBT1 mRNA | CTD | PMID:24136188 | SFMBT1 | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of SFMBT1 mRNA | CTD | PMID:28001369 | |